BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31821410)

  • 21. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes.
    Nicks AM; Kesteven SH; Li M; Wu J; Chan AY; Naqvi N; Husain A; Feneley MP; Smith NJ; Iismaa SE; Graham RM
    Sci Rep; 2020 Sep; 10(1):15318. PubMed ID: 32948799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy.
    Eleftheriadou O; Boguslavskyi A; Longman MR; Cowan J; Francois A; Heads RJ; Wadzinski BE; Ryan A; Shattock MJ; Snabaitis AK
    Basic Res Cardiol; 2017 Jul; 112(4):37. PubMed ID: 28526910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Akt pathway mediates the protective effects of myeloid differentiation protein 1 in pathological cardiac remodelling.
    Peng J; Zeng G; Zhong P; Wang G; Lei C; Tian G; Chen J; Wu J; Shen C
    ESC Heart Fail; 2021 Aug; 8(4):3214-3222. PubMed ID: 34041859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.
    Cao F; Maguire ML; McAndrew DJ; Lake HA; Neubauer S; Zervou S; Schneider JE; Lygate CA
    Basic Res Cardiol; 2020 Jan; 115(2):12. PubMed ID: 31925563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
    Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.
    Moreno MU; Gallego I; López B; González A; Fortuño A; San José G; Valencia F; Gómez-Doblas JJ; de Teresa E; Shah AM; Díez J; Zalba G
    Clin Sci (Lond); 2013 Sep; 125(6):291-300. PubMed ID: 23550626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and structural transition mechanisms in long-term volume overload.
    Mohamed BA; Schnelle M; Khadjeh S; Lbik D; Herwig M; Linke WA; Hasenfuss G; Toischer K
    Eur J Heart Fail; 2016 Apr; 18(4):362-71. PubMed ID: 26694078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
    Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
    Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
    J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36.
    Smolka C; Schlösser D; Koentges C; Tarkhnishvili A; Gorka O; Pfeifer D; Bemtgen X; Asmussen A; Groß O; Diehl P; Moser M; Bode C; Bugger H; Grundmann S; Pankratz F
    FASEB J; 2021 Nov; 35(11):e21956. PubMed ID: 34605573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.
    De Acetis M; Notte A; Accornero F; Selvetella G; Brancaccio M; Vecchione C; Sbroggiò M; Collino F; Pacchioni B; Lanfranchi G; Aretini A; Ferretti R; Maffei A; Altruda F; Silengo L; Tarone G; Lembo G
    Circ Res; 2005 May; 96(10):1087-94. PubMed ID: 15860758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2.
    Yoon S; Kim M; Min HK; Lee YU; Kwon DH; Lee M; Lee S; Kook T; Joung H; Nam KI; Ahn Y; Kim YK; Kim J; Park WJ; McMullen JR; Eom GH; Kook H
    Cardiovasc Res; 2019 Nov; 115(13):1850-1860. PubMed ID: 30596969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
    Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
    J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
    Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
    Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.
    Zhao QD; Viswanadhapalli S; Williams P; Shi Q; Tan C; Yi X; Bhandari B; Abboud HE
    Circulation; 2015 Feb; 131(7):643-55. PubMed ID: 25589557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
    Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
    Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.